Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 294-299

  Peirano, Gisele ^a   Van Der Bij, Akke K ^c,d   Gregson, Daniel B ^a,b   Pitout, Johann D D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M14; BETA LACTAMASE CTX M15; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; UROSEPSIS;

AGED; AGED, 80 AND OVER; ALBERTA; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CANADA; CLUSTER ANALYSIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING;

ESCHERICHIA COLI;

EID: 84856151388     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06025-11     Document Type: Article

References (44)

1. Blanco J, et al. 2011. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b: H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 66:2011-2021.
2. Canton R, Coque TM. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
3. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
4. Clermont O, et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
5. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Coque TM, et al. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200. (Pubitemid 351213667)
8. Cortes P, et al. 2010. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 76:2799-2805.
9. Fam N, et al. 2011. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb. Drug Resist. 17:67-73.
10. Friedman ND, et al. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of communityacquired infections. Ann. Intern. Med. 137:791-797. (Pubitemid 35334450)
11. Hornsey M, Phee L, Wareham DW. 2011. A novel variant (NDM-5) of the New Delhi metallo-β-lactamase (NDM) in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55:5952-5954.
12. Hunter SB, et al. 2005. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J. Clin. Microbiol. 43:1045-1050. (Pubitemid 40364915)
13. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
14. Jones GL, et al. 2008. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 62:1245-1251.
15. Kim J, et al. 2011. Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from Korea. J. Antimicrob. Chemother. 66:1263-1268.
16. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. 2008. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin. Microbiol. Infect. 14:1041-1047. (Pubitemid 352748845)
17. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. 2001. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32:1162-1171. (Pubitemid 32390110)
18. Lee MY, et al. 2010. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J. Infect. 60:146-153.
19. Mihaila L, et al. 2010. Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J. Antimicrob. Chemother. 65:1537-1539.
20. Mshana SE, et al. 2011. Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin. Microbiol. Infect. 17:1279-1282.
21. Mushtaq S, et al. 2011. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J. Antimicrob. Chemother. 66:2002-2005.
22. Okeke IN, et al. 2010. Multi-locus sequence typing of enteroaggregative Escherichia coli isolates from Nigerian children uncovers multiple lineages. PLoS One 5:e14093.
23. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. 2006. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955. (Pubitemid 44684926)
24. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
25. Peirano G, Pitout JD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321.
26. Pitout JD. 2010. Infections with extended-spectrum beta-lactamase- producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333.
27. Pitout JD, et al. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286. (Pubitemid 46586806)
28. Pitout JD, Gregson DB, Campbell L, Laupland KB. 2009. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 53:2846-2851.
29. Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB. 2005. Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region. J. Clin. Microbiol. 43:2844-2849. (Pubitemid 40834300)
30. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. (Pubitemid 351249250)
31. Poirel L, et al. 2011. Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob. Agents Chemother. 55:4937-4938.
32. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874. (Pubitemid 44198719)
33. Rodriguez-Bano J, Pascual A. 2008. Clinical significance of extended-spectrum beta-lactamases. Expert Rev. Anti Infect. Ther. 6:671-683.
34. Russell JA. 2006. Management of sepsis. N. Engl. J. Med. 355:1699-1713. (Pubitemid 44583960)
35. Smet A, et al. 2010. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb. Drug Resist. 16:129-134.
36. Sullivan CB, Diggle MA, Clarke SC. 2005. Multilocus sequence typing: data analysis in clinical microbiology and public health. Mol. Biotechnol. 29:245-254. (Pubitemid 41411177)
37. Suzuki S, et al. 2009. Change in the prevalence of extended-spectrum- beta-lactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 63:72-79.
38. Tenover FC, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
39. Tumbarello M, et al. 2007. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51:1987-1994. (Pubitemid 46903084)
40. CTX-M-14 is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, andDin Spain. Antimicrob. Agents Chemother. 53:5204-5212.
41. van der Bij AK, et al. 2011. Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam area, Netherlands. Antimicrob. Agents Chemother. 55:3576-3578.
42. Yamamoto T, Takano T, Iwao Y, Hishinuma A. 2011. Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan. J. Infect. Chemother. 17:435-439.
43. Yamane K, Wachino J, Suzuki S, Arakawa Y. 2008. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 52:1564-1566. (Pubitemid 351522037)
44. Zong Z, Yu R. 2010. Escherichia coli carrying the blaCTX-M-15 gene of ST648. J. Med. Microbiol. 59:1536 -1537.